Real-time enrollment status for this moderate-to-severe atopic dermatitis clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 6:35 PM UTC
| NCT Number | NCT07660835 |
| Recruiting Status | Recruiting |
| Condition | Moderate-to-Severe Atopic Dermatitis |
| Phase | PHASE2 |
| Target Enrollment | 35 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Galderma R&D |
| Last Updated on CT.gov | August 14, 2026 (2 weeks ago) |
As of August 31, 2026: Clinical trial NCT07660835 is currently recruiting participants. This phase2 study for moderate-to-severe atopic dermatitis is actively seeking new participants at 1 location across the United States. The study is sponsored by Galderma R&D. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07660835 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07660835 was last updated 2 weeks ago (August 14, 2026). HelloStudys verifies this status automatically.